Latest on Pharmaceutical Industry

news

Achilles Therapeutics receives CTA approval for Phase I/II Study in Non-Small Cell Lung Cancer

Achilles Therapeutics (“Achilles””), a biopharmaceutical company developing personalised cancer immunotherapies, today announces that its Clinical Trial Application (CTA) to conduct a Phase I/II study with its lead..Read More...

JW Pharmaceutical gains Korean approval for Hemlibra

JW Pharmaceutical said Sunday that it had gained the South Korean drug regulator’s nod to begin domestic sales of the hemophilia treatment Hemlibra, developed by Chugai, a Roche-owned company. JW Pharmaceutical obta..Read More...

events

23

Precision Medicine World Conference 2019

Santa Clara Convention Center,
USA,
Personalized Medicine World Conference

25

Cell & Gene Therapy World

Hyatt Regency Miami,
USA,
Clarion Events Pte. Ltd

Press Releases

Antibe Therapeutics Receives Approval to Initiate Part Two of Phase 2B Dose-Ranging, Efficacy Study for ATB-346

Antibe Therapeutics Inc a leader in developing safer therapeutics for pain and inflammation is pleased to announce that it has received approval from Health Canada to initiate the second part of its Phase 2B doseranging .. Read More...

US FDA Approves ONTRUZANT® (trastuzumab-dttb), Samsung Bioepis’ First Oncology Medicine in the United States

Samsung Bioepis Co Ltd today announced that the US Food and Drug Administration FDA has approved ONTRUZANT trastuzumabdttb a biosimilar referencing HERCEPTIN 1 trastuzumab across all eligible indications namely adjuvant .. Read More...

Suppliers of the Month

Product Launch

Articles

Videos

Latest Reports

whitepapers

Latest Projects

testimonials

Expert Talk

Messe Muenchen India Pvt. Ltd.

Messe Muenchen India Pvt. Ltd. As per the World Bank India has made a substantial effort in attempting to address environmental challenges It has endorsed rigorous environmental legislation and has created relevant institutions to monitor and enforce legislation In response to the threat of climate change the Prime Ministers Nati. Read More...
Bhupinder Singh
Chief Executive Officer